Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Prices Senior Notes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today priced its previously announced senior notes being issued to partially fund its $3.5 billion purchase of Phadia.

In total, the company is offering $2.1 billion in senior notes — $1 billion worth of 2.25 percent notes due 2016 at an issue price of 99.826 percent of the principal amount, and $1.1 billion of 3.6 percent notes due in 2021 at an issue price of 99.809 percent of the principal amount.

The issuance of the notes is expected to close on Aug. 16 and will pay interest on a semi-annual basis.

Ratings firm Fitch yesterday assigned an "A-" rating to the notes.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.